Literature DB >> 10845928

Constitutive activation of transcription factor AP-1 in primary adult T-cell leukemia cells.

N Mori1, M Fujii, K Iwai, S Ikeda, Y Yamasaki, T Hata, Y Yamada, Y Tanaka, M Tomonaga, N Yamamoto.   

Abstract

Human T-cell leukemia virus type-I (HTLV-I) is the etiologic agent of adult T-cell leukemia (ATL). This study examined the status of the oncogenic transcription factor AP-1 in leukemic cells freshly isolated from patients with ATL. Leukemic cells from peripheral blood of all patients with ATL exhibited constitutive AP-1 DNA binding activity, whereas mononuclear cells from normal individuals did not. In agreement with previous studies, HTLV-I transforming protein, Tax, was found to stimulate the DNA binding activity of AP-1 in a T-cell line. However, HTLV-I genes, including Tax, were not significantly expressed in leukemic cells freshly obtained from patients with ATL. Moreover, all T-cell lines derived from leukemic cells of patients with ATL also displayed constitutive AP-1 DNA binding activity, but expressed little Tax protein. Thus, leukemic cells of patients with ATL appear to have Tax-independent mechanisms that induce AP-1 activity, both in vivo and in vitro. In antibody supershift experiments, AP-1 in fresh leukemic cells and ATL-derived cell lines were found to contain JunD. Consistently, all primary ATL cells and ATL-derived cell lines expressed high levels of JunD messenger RNA. Our results suggest that AP-1 is activated in leukemic cells of patients with ATL through a Tax-independent mechanism and this may play a role in the deregulated phenotypes of ATL leukemic cells. (Blood. 2000;95:3915-3921)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845928

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

2.  Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting function of ubiquitination.

Authors:  Osamu Isono; Takayuki Ohshima; Yasushi Saeki; Jun Matsumoto; Makoto Hijikata; Keiji Tanaka; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

3.  Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.

Authors:  Jixin Ding; Melissa L Fishel; April M Reed; Erin McAdams; Magdalena B Czader; Angelo A Cardoso; Mark R Kelley
Journal:  Mol Cancer Ther       Date:  2017-04-26       Impact factor: 6.261

4.  Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.

Authors:  Mariko Tomita; Gregg L Semenza; Canine Michiels; Takehiro Matsuda; Jun-Nosuke Uchihara; Taeko Okudaira; Yuetsu Tanaka; Naoya Taira; Kazuiku Ohshiro; Naoki Mori
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

Review 5.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

6.  Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1.

Authors:  Megan Brown; Marcia Bellon; Christophe Nicot
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

7.  Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.

Authors:  Naoki Mori; Takehiro Matsuda; Masayuki Tadano; Takao Kinjo; Yasuaki Yamada; Kunihiro Tsukasaki; Shuichi Ikeda; Yoshihiro Yamasaki; Yuetsu Tanaka; Takao Ohta; Teruo Iwamasa; Masao Tomonaga; Naoki Yamamoto
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B.

Authors:  Stephan Mathas; Michael Hinz; Ioannis Anagnostopoulos; Daniel Krappmann; Andreas Lietz; Franziska Jundt; Kurt Bommert; Fatima Mechta-Grigoriou; Harald Stein; Bernd Dörken; Claus Scheidereit
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

Review 9.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01

10.  Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol.

Authors:  Yoshiaki Machijima; Chie Ishikawa; Shigeki Sawada; Taeko Okudaira; Jun-nosuke Uchihara; Yuetsu Tanaka; Naoya Taira; Naoki Mori
Journal:  Retrovirology       Date:  2009-01-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.